In our present work, we verified that CEBPA-DT was upregulated in HCC tissues compared to non-tumor tissues; high CEBPA-DT expression was relevant to inferior prognosis of HCC patients. This evidence concerns the gene CEBPA and hepatocellular carcinoma.